{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:40:59Z","timestamp":1776091259653,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81860133"],"award-info":[{"award-number":["81860133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Jiangxi Provincial Department of Science and Technology","award":["20192BAB205022"],"award-info":[{"award-number":["20192BAB205022"]}]},{"name":"The central government guides local science and technology development projects","award":["20192ZDG04041"],"award-info":[{"award-number":["20192ZDG04041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Idiopathic membranous nephropathy (IMN) belongs to an important pathogenic category of adult nephrotic syndrome. PLA2R1 exposure is critical for triggering the pathogenesis of PLA2R1-related IMN. However, the pathogenesis of IMN and the molecular mechanism of treatment remain to be further clarified. The expression changes of activated protein C (APC) and PLA2R1 in IMN patients were quantified by qPCR. A zymosan activated serum (ZAS)-induced IMN podocyte model was established in vitro. Podocyte apoptosis was detected via flow cytometry and caspase\u20113 assay. The expression levels of APC, p-ERK1\/2, ERK1\/2, YB-1 and PLA2R1 were detected by western blotting. The regulation relationship between YB-1 and PLA2R1 was detected by dual fluorescent reporter system. In IMN patients, the expression level of PLA2R1 was increased, whereas the expression level of APC was decreased. When APC was added to podocytes in vitro, the phosphorylation of ERK1\/2 was increased, which could promote the translocation of YB-1 to the nucleus that reduces the expression of PLA2R1 at the cellular transcriptional level, thereby inhibiting podocyte apoptosis. Our study is the first to report that APC can improve membranous nephropathy by affecting podocyte apoptosis through the ERK1\/2\/YB-1\/PLA2R1 axis. This study will provide a new targeted therapy for IMN patients with high PLA2R1 expression.<\/jats:p>","DOI":"10.1007\/s11010-022-04650-7","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T04:22:10Z","timestamp":1672633330000},"page":"1999-2011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["APC ameliorates idiopathic membranous nephropathy by affecting podocyte apoptosis through the ERK1\/2\/YB-1\/PLA2R1 axis"],"prefix":"10.1007","volume":"478","author":[{"given":"Ben","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"key":"4650_CR1","doi-asserted-by":"publisher","first-page":"760482","DOI":"10.3389\/fphar.2021.760482","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L, Chen X, Li C, Xu P, Mao W, Liang X, Zuo Q, Ma W, Guo X, Bao K (2022) Real-world effects of Chinese herbal medicine for idiopathic membranous nephropathy (REACH-MN): protocol of a registry-based cohort study. Front Pharmacol 12:760482","journal-title":"Front Pharmacol"},{"key":"4650_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser WG (2017) Primary membranous nephropathy. Clin J Am Soc Nephrol 12:983\u2013997","journal-title":"Clin J Am Soc Nephrol"},{"key":"4650_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.ajkd.2020.10.009","volume":"77","author":"L Alsharhan","year":"2021","unstructured":"Alsharhan L, Beck LH (2021) Membranous nephropathy: core curriculum 2021. Am J Kidney Dis 77:440\u2013453","journal-title":"Am J Kidney Dis"},{"key":"4650_CR4","doi-asserted-by":"publisher","first-page":"e930097","DOI":"10.12659\/MSM.930097","volume":"27","author":"L Wu","year":"2021","unstructured":"Wu L, Lai J, Ling Y, Weng Y, Zhou S, Wu S, Jiang S, Ding X, Jin X, Yu K (2021) A review of the current practice of diagnosis and treatment of idiopathic membranous nephropathy in China. Med Sci Monit 27:e930097\u2013e930101","journal-title":"Med Sci Monit"},{"key":"4650_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11\u201321","journal-title":"N Engl J Med"},{"key":"4650_CR6","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay A-S (2014) Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277\u20132287","journal-title":"N Engl J Med"},{"key":"4650_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","volume":"97","author":"S Sethi","year":"2020","unstructured":"Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross L, Ravindran A, Buob D, Jadoul M, Fervenza FC (2020) Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 97:163\u2013174","journal-title":"Kidney Int"},{"key":"4650_CR8","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3389\/fimmu.2020.01846","volume":"11","author":"W Liu","year":"2020","unstructured":"Liu W, Gao C, Dai H, Dong Z, Zheng Y, Gao Y, Liu Z, Feng Z, Tian X, Liu B (2020) Idiopathic membranous nephropathy: glomerular pathological pattern caused by extrarenal immunity activity. Front Immunol 11:2560\u20132572","journal-title":"Front Immunol"},{"key":"4650_CR9","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3389\/fimmu.2019.01809","volume":"10","author":"W Liu","year":"2019","unstructured":"Liu W, Gao C, Dai H, Zheng Y, Dong Z, Gao Y, Liu F, Zhang Z, Liu Z, Liu W, Liu B, Liu Q, Shi J (2019) Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role. Front Immunol 10:1809","journal-title":"Front Immunol"},{"key":"4650_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0165-6147(99)01300-0","volume":"20","author":"G Lambeau","year":"1999","unstructured":"Lambeau G, Lazdunski M (1999) Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol Sci 20:162\u2013170","journal-title":"Trends Pharmacol Sci"},{"key":"4650_CR11","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1016\/j.jmb.2017.10.019","volume":"429","author":"Y Dong","year":"2017","unstructured":"Dong Y, Cao L, Tang H, Shi X, He Y (2017) Structure of human M-type phospholipase A2 receptor revealed by cryo-electron microscopy. J Mol Biol 429:3825\u20133835","journal-title":"J Mol Biol"},{"key":"4650_CR12","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ki.1992.166","volume":"41","author":"D Kerjaschki","year":"1992","unstructured":"Kerjaschki D (1992) Molecular pathogenesis of membranous nephropathy. Kidney Int 41:1090\u20131105","journal-title":"Kidney Int"},{"key":"4650_CR13","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1080\/15384101.2018.1542901","volume":"17","author":"D Liu","year":"2018","unstructured":"Liu D, Liu F, Wang X, Qiao Y, Pan S, Yang Y, Hu Y, Zhang Y, Tian F, Liu Z (2018) MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor. Cell Cycle 17:2484\u20132495","journal-title":"Cell Cycle"},{"key":"4650_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112349","volume":"144","author":"TT-Y Chiou","year":"2021","unstructured":"Chiou TT-Y, Chau Y-Y, Chen J-B, Hsu H-H, Hung S-P, Lee W-C (2021) Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K\/AKT\/mTOR pathway. Biomed Pharmacother 144:112349","journal-title":"Biomed Pharmacother"},{"key":"4650_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","volume":"132","author":"JH Griffin","year":"2018","unstructured":"Griffin JH, Zlokovic BV, Mosnier LO (2018) Activated protein C, protease activated receptor 1, and neuroprotection. Blood 132:159\u2013169","journal-title":"Blood"},{"key":"4650_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1538-7836.2007.02491.x","volume":"5","author":"JH Griffin","year":"2007","unstructured":"Griffin JH, Fern\u00e1ndez JA, Gale AJ, Mosnier LO (2007) Activated protein C. J Thromb Haemost 5:73\u201380","journal-title":"J Thromb Haemost"},{"key":"4650_CR17","doi-asserted-by":"publisher","first-page":"C833","DOI":"10.1152\/ajpcell.00003.2010","volume":"300","author":"C Guitton","year":"2011","unstructured":"Guitton C, Cottereau A, G\u00e9rard N, Quillard T, Chauveau A, Devalli\u00e8re J, Tonnerre P, Charreau B (2011) Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-\u03baB, and ERK1\/2 MAP kinases. Am J Physiol Cell Physiol 300:C833\u2013C842","journal-title":"Am J Physiol Cell Physiol"},{"key":"4650_CR18","doi-asserted-by":"publisher","first-page":"2000562","DOI":"10.3389\/fcvm.2021.758158","volume":"8","author":"X Zhong","year":"2021","unstructured":"Zhong X, Wang T, Xie Y, Wang M, Zhang W, Dai L, Lai J, Nie X, He X, Madhusudhan T (2021) Activated protein C ameliorates diabetic cardiomyopathy via modulating OTUB1\/YB-1\/MEF2B axis. Front Cardiovasc Med 8:2000562","journal-title":"Front Cardiovasc Med"},{"key":"4650_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1073\/pnas.1218667110","volume":"110","author":"F Bock","year":"2013","unstructured":"Bock F, Shahzad K, Wang H, Stoyanov S, Wolter J, Dong W, Pelicci PG, Kashif M, Ranjan S, Schmidt S (2013) Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci USA 110:648\u2013653","journal-title":"Proc Natl Acad Sci USA"},{"key":"4650_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/wrna.1200","volume":"5","author":"DN Lyabin","year":"2014","unstructured":"Lyabin DN, Eliseeva IA, Ovchinnikov LP (2014) YB-1 protein: functions and regulation. WIREs RNA 5:95\u2013110","journal-title":"WIREs RNA"},{"key":"4650_CR21","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3390\/cancers13133306","volume":"13","author":"A Shah","year":"2021","unstructured":"Shah A, Lindquist JA, Rosendahl L, Schmitz I, Mertens PR (2021) Novel insights into YB-1 signaling and cell death decisions. Cancers 13:3306","journal-title":"Cancers"},{"key":"4650_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clim.2018.07.002","volume":"194","author":"L Gibbert","year":"2018","unstructured":"Gibbert L, Hermert D, Wang J, Breitkopf D, Alidousty C, Neusser M, Cohen CD, Gr\u00f6ne E, Macheleidt I, Rauen T, Braun GS, Floege J, Ostendorf T, Raffetseder U (2018) YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy. Clin Immunol 194:67\u201374","journal-title":"Clin Immunol"},{"key":"4650_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/JCI116157","volume":"91","author":"S Ishikawa","year":"1993","unstructured":"Ishikawa S, Tsukada H, Bhattacharya J (1993) Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung. J Clin Invest 91:103\u2013109","journal-title":"J Clin Invest"},{"key":"4650_CR24","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1038\/s41598-017-07889-z","volume":"7","author":"WJ Liu","year":"2017","unstructured":"Liu WJ, Li ZH, Chen XC, Zhao XL, Zhong Z, Yang C, Wu HL, An N, Li WY, Liu HF (2017) Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy. Sci Rep 7:8643","journal-title":"Sci Rep"},{"key":"4650_CR25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00535-007-2104-2","volume":"42","author":"P Chen","year":"2007","unstructured":"Chen P, Zhang Y, Qiao M, Yuan Y (2007) Activated protein C, an anticoagulant polypeptide, ameliorates severe acute pancreatitis via regulation of mitogen-activated protein kinases. J Gastroenterol 42:887\u2013896","journal-title":"J Gastroenterol"},{"key":"4650_CR26","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1161\/ATVBAHA.107.153734","volume":"27","author":"LA O\u2019Brien","year":"2007","unstructured":"O\u2019Brien LA, Richardson MA, Mehrbod SF, Berg DT, Gerlitz B, Gupta A, Grinnell BW (2007) Activated protein C decreases tumor necrosis factor\u2013related apoptosis-inducing ligand by an EPCR-independent mechanism involving Egr-1\/Erk-1\/2 activation. Arterioscler Thromb Vasc Biol 27:2634\u20132641","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4650_CR27","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.jbc.2022.101989","volume":"298","author":"X Zhong","year":"2022","unstructured":"Zhong X, Wang T, Zhang W, Wang M, Xie Y, Dai L, He X, Madhusudhan T, Zeng H, Wang H (2022) ERK\/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1. J Biol Chem 298:101989","journal-title":"J Biol Chem"},{"key":"4650_CR28","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay A-S, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RAK, Lambeau G (2014) Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277\u20132287","journal-title":"N Engl J Med"},{"key":"4650_CR29","doi-asserted-by":"publisher","first-page":"8163298","DOI":"10.1155\/2021\/8163298","volume":"2021","author":"P Zhang","year":"2021","unstructured":"Zhang P, Huang W, Zheng Q, Tang J, Dong Z, Jiang Y, Liu Y, Liu W (2021) A novel insight into the role of PLA2R and THSD7A in membranous nephropathy. J Immunol Res 2021:8163298","journal-title":"J Immunol Res"},{"key":"4650_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41581-022-00564-1","volume":"18","author":"E Hoxha","year":"2022","unstructured":"Hoxha E, Reinhard L, Stahl RAK (2022) Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol 18:466\u2013478","journal-title":"Nat Rev Nephrol"},{"key":"4650_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18:134\u2013147","journal-title":"Nat Rev Immunol"},{"key":"4650_CR32","first-page":"S94","volume":"87","author":"EY Rybalkina","year":"2022","unstructured":"Rybalkina EY, Moiseeva NI (2022) Role of YB-1 Protein in Inflammation. Biochemistry 87:S94\u2013S102","journal-title":"Biochemistry"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04650-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04650-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04650-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T08:06:30Z","timestamp":1689840390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04650-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4650"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04650-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"7 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}